Software Application for Disease Research, Drug Discovery and Biomarker Research
Foster City: AB SCIEX announced the launch of the first mass-spectrometry-based software application specifically designed to advance the study of lipidomics. LipidView” Software is the first commercially available software using the analytical accuracy and speed of mass spectrometry to characterize molecules in studies of lipidomics, which is an emerging field of systems biology that is being applied for disease research, drug discovery and biomarker research for potential use in clinical settings.
Researchers are increasingly exploring the range of functions that lipids have within the human body, including energy storage, cell membrane structure and hormone signaling. LipidView software responds to the need of lipidomics researchers who have been seeking tools focused specifically on this new discipline to provide more accurate and faster results. LipidView Software is an automated data processing tool that enables researchers to more effectively identify and quantify lipids from complex samples, providing standardized information from a catalog of more than 40 lipid classes and 23.000 possible lipid species.
Among the organizations adopting LipidView Softare adopting LipidView Software is Zora Biosciences, a leader in providing advanced lipidomics services to the pharmaceutical industry. Researchers at Zora Biosciences are supporting drug discovery projects by delivering critical information about lipids that can be used to help develop more effective drugs.
They are using LipidView Software to significantly accelerate data processing of mass spectrometry-based analysis for lipid profiling as a means to better understand complex medical conditions, including diabetes and obesity, in efforts to develop better drugs and discover useful lipid biomarkers.
No comments:
Post a Comment